Sphera Funds Management Ltd. Vbi Vaccines Inc Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$2.75 - $3.85 $1.83 Million - $2.57 Million	-666,284 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$3.5 - $4.47 $468,006 - $597,710	-133,716 Reduced 16.71%	666,284 $2.33 Million
Q4 2017 Feb 12, 2018	BUY	$3.29 - $5.03 $2.63 Million - $4.02 Million	800,000	800,000 $3.42 Million

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.